Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Heptares Therapeutics Ltd.

www.soseiheptares.com

Latest From Heptares Therapeutics Ltd.

Biotech Entrepreneur Aldag Inspired By Italy's Genespire

Jörn Aldag, who has over 20 years of leadership experience in the life sciences industry, including CEO of gene therapy pioneer uniQure, tells Scrip that the research carried at the world-class Italian research institute SR-Tiget.

Gene Therapy Appointments

Sosei Heptares Seeks Acquisitions After $200m Boost

The Japanese firm with R&D operations in the UK is conducting a search to find "a potentially transformative acquisition," helped by a significant financing round.

M & A Financing
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register